Global Opioid Induced Constipation Drugs Market Size, Status and Forecast 2020-2026

Global Opioid Induced Constipation Drugs Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Opioid Induced Constipation Drugs Revenue
1.4 Market by Type
1.4.1 Global Opioid Induced Constipation Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Lubiprostone
1.4.3 Methyl Naltrexone Bromide
1.4.4 Naldemedine
1.4.5 Alvimopan
1.4.6 Other
1.5 Market by Application
1.5.1 Global Opioid Induced Constipation Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Opioid Induced Constipation Drugs Market Perspective (2015-2026)
2.2 Global Opioid Induced Constipation Drugs Growth Trends by Regions
2.2.1 Opioid Induced Constipation Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Opioid Induced Constipation Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Opioid Induced Constipation Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Opioid Induced Constipation Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Opioid Induced Constipation Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Opioid Induced Constipation Drugs Players by Market Size
3.1.1 Global Top Opioid Induced Constipation Drugs Players by Revenue (2015-2020)
3.1.2 Global Opioid Induced Constipation Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Opioid Induced Constipation Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Opioid Induced Constipation Drugs Market Concentration Ratio
3.2.1 Global Opioid Induced Constipation Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Opioid Induced Constipation Drugs Revenue in 2019
3.3 Opioid Induced Constipation Drugs Key Players Head office and Area Served
3.4 Key Players Opioid Induced Constipation Drugs Product Solution and Service
3.5 Date of Enter into Opioid Induced Constipation Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Opioid Induced Constipation Drugs Historic Market Size by Type (2015-2020)
4.2 Global Opioid Induced Constipation Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
5.2 Global Opioid Induced Constipation Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Opioid Induced Constipation Drugs Market Size (2015-2020)
6.2 Opioid Induced Constipation Drugs Key Players in North America (2019-2020)
6.3 North America Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
6.4 North America Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Opioid Induced Constipation Drugs Market Size (2015-2020)
7.2 Opioid Induced Constipation Drugs Key Players in Europe (2019-2020)
7.3 Europe Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
7.4 Europe Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
8 China
8.1 China Opioid Induced Constipation Drugs Market Size (2015-2020)
8.2 Opioid Induced Constipation Drugs Key Players in China (2019-2020)
8.3 China Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
8.4 China Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Opioid Induced Constipation Drugs Market Size (2015-2020)
9.2 Opioid Induced Constipation Drugs Key Players in Japan (2019-2020)
9.3 Japan Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
9.4 Japan Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Opioid Induced Constipation Drugs Market Size (2015-2020)
10.2 Opioid Induced Constipation Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
11 India
11.1 India Opioid Induced Constipation Drugs Market Size (2015-2020)
11.2 Opioid Induced Constipation Drugs Key Players in India (2019-2020)
11.3 India Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
11.4 India Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Opioid Induced Constipation Drugs Market Size (2015-2020)
12.2 Opioid Induced Constipation Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Opioid Induced Constipation Drugs Market Size by Type (2015-2020)
12.4 Central & South America Opioid Induced Constipation Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Ironwood Pharmaceuticals Inc
13.1.1 Ironwood Pharmaceuticals Inc Company Details
13.1.2 Ironwood Pharmaceuticals Inc Business Overview
13.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation Drugs Introduction
13.1.4 Ironwood Pharmaceuticals Inc Revenue in Opioid Induced Constipation Drugs Business (2015-2020))
13.1.5 Ironwood Pharmaceuticals Inc Recent Development
13.2 Daiichi Sankyo Co Ltd
13.2.1 Daiichi Sankyo Co Ltd Company Details
13.2.2 Daiichi Sankyo Co Ltd Business Overview
13.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation Drugs Introduction
13.2.4 Daiichi Sankyo Co Ltd Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
13.2.5 Daiichi Sankyo Co Ltd Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Opioid Induced Constipation Drugs Introduction
13.3.4 Pfizer Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Progenics Pharmaceuticals Inc
13.4.1 Progenics Pharmaceuticals Inc Company Details
13.4.2 Progenics Pharmaceuticals Inc Business Overview
13.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation Drugs Introduction
13.4.4 Progenics Pharmaceuticals Inc Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
13.4.5 Progenics Pharmaceuticals Inc Recent Development
13.5 Shionogi & Co., Ltd
13.5.1 Shionogi & Co., Ltd Company Details
13.5.2 Shionogi & Co., Ltd Business Overview
13.5.3 Shionogi & Co., Ltd Opioid Induced Constipation Drugs Introduction
13.5.4 Shionogi & Co., Ltd Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
13.5.5 Shionogi & Co., Ltd Recent Development
13.6 Allergan Plc
13.6.1 Allergan Plc Company Details
13.6.2 Allergan Plc Business Overview
13.6.3 Allergan Plc Opioid Induced Constipation Drugs Introduction
13.6.4 Allergan Plc Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
13.6.5 Allergan Plc Recent Development
13.7 Nektar Therapeutics
13.7.1 Nektar Therapeutics Company Details
13.7.2 Nektar Therapeutics Business Overview
13.7.3 Nektar Therapeutics Opioid Induced Constipation Drugs Introduction
13.7.4 Nektar Therapeutics Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
13.7.5 Nektar Therapeutics Recent Development
13.8 Purdue Pharma
13.8.1 Purdue Pharma Company Details
13.8.2 Purdue Pharma Business Overview
13.8.3 Purdue Pharma Opioid Induced Constipation Drugs Introduction
13.8.4 Purdue Pharma Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
13.8.5 Purdue Pharma Recent Development
13.9 S.L.A. Pharma AG
13.9.1 S.L.A. Pharma AG Company Details
13.9.2 S.L.A. Pharma AG Business Overview
13.9.3 S.L.A. Pharma AG Opioid Induced Constipation Drugs Introduction
13.9.4 S.L.A. Pharma AG Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
13.9.5 S.L.A. Pharma AG Recent Development
13.10 Mundipharma International Limited
13.10.1 Mundipharma International Limited Company Details
13.10.2 Mundipharma International Limited Business Overview
13.10.3 Mundipharma International Limited Opioid Induced Constipation Drugs Introduction
13.10.4 Mundipharma International Limited Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
13.10.5 Mundipharma International Limited Recent Development
13.11 Ono Pharmaceutical Co., Ltd
10.11.1 Ono Pharmaceutical Co., Ltd Company Details
10.11.2 Ono Pharmaceutical Co., Ltd Business Overview
10.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation Drugs Introduction
10.11.4 Ono Pharmaceutical Co., Ltd Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
10.11.5 Ono Pharmaceutical Co., Ltd Recent Development
13.12 Takeda Pharmaceutical Company Limited
10.12.1 Takeda Pharmaceutical Company Limited Company Details
10.12.2 Takeda Pharmaceutical Company Limited Business Overview
10.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation Drugs Introduction
10.12.4 Takeda Pharmaceutical Company Limited Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
10.12.5 Takeda Pharmaceutical Company Limited Recent Development
13.13 Theravance Biopharma Inc
10.13.1 Theravance Biopharma Inc Company Details
10.13.2 Theravance Biopharma Inc Business Overview
10.13.3 Theravance Biopharma Inc Opioid Induced Constipation Drugs Introduction
10.13.4 Theravance Biopharma Inc Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
10.13.5 Theravance Biopharma Inc Recent Development
13.14 Bausch Health
10.14.1 Bausch Health Company Details
10.14.2 Bausch Health Business Overview
10.14.3 Bausch Health Opioid Induced Constipation Drugs Introduction
10.14.4 Bausch Health Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
10.14.5 Bausch Health Recent Development
13.15 Cosmo Pharmaceuticals SA
10.15.1 Cosmo Pharmaceuticals SA Company Details
10.15.2 Cosmo Pharmaceuticals SA Business Overview
10.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation Drugs Introduction
10.15.4 Cosmo Pharmaceuticals SA Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
10.15.5 Cosmo Pharmaceuticals SA Recent Development
13.16 Daewoong Pharmaceutical
10.16.1 Daewoong Pharmaceutical Company Details
10.16.2 Daewoong Pharmaceutical Business Overview
10.16.3 Daewoong Pharmaceutical Opioid Induced Constipation Drugs Introduction
10.16.4 Daewoong Pharmaceutical Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
10.16.5 Daewoong Pharmaceutical Recent Development
13.17 C.B. Fleet Company
10.17.1 C.B. Fleet Company Company Details
10.17.2 C.B. Fleet Company Business Overview
10.17.3 C.B. Fleet Company Opioid Induced Constipation Drugs Introduction
10.17.4 C.B. Fleet Company Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
10.17.5 C.B. Fleet Company Recent Development
13.18 Sucampo Pharmaceuticals
10.18.1 Sucampo Pharmaceuticals Company Details
10.18.2 Sucampo Pharmaceuticals Business Overview
10.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation Drugs Introduction
10.18.4 Sucampo Pharmaceuticals Revenue in Opioid Induced Constipation Drugs Business (2015-2020)
10.18.5 Sucampo Pharmaceuticals Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Opioid Induced Constipation Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Opioid Induced Constipation Drugs Revenue
Table 3. Ranking of Global Top Opioid Induced Constipation Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Opioid Induced Constipation Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Lubiprostone
Table 6. Key Players of Methyl Naltrexone Bromide
Table 7. Key Players of Naldemedine
Table 8. Key Players of Alvimopan
Table 9. Key Players of Other
Table 10. Global Opioid Induced Constipation Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Opioid Induced Constipation Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Opioid Induced Constipation Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Opioid Induced Constipation Drugs Market Share by Regions (2015-2020)
Table 14. Global Opioid Induced Constipation Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Opioid Induced Constipation Drugs Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Opioid Induced Constipation Drugs Market Growth Strategy
Table 20. Main Points Interviewed from Key Opioid Induced Constipation Drugs Players
Table 21. Global Opioid Induced Constipation Drugs Revenue by Players (2015-2020) (Million US$)
Table 22. Global Opioid Induced Constipation Drugs Market Share by Players (2015-2020)
Table 23. Global Top Opioid Induced Constipation Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Constipation Drugs as of 2019)
Table 24. Global Opioid Induced Constipation Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Opioid Induced Constipation Drugs Product Solution and Service
Table 27. Date of Enter into Opioid Induced Constipation Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Opioid Induced Constipation Drugs Market Size by Type (2015-2020) (Million US$)
Table 30. Global Opioid Induced Constipation Drugs Market Size Share by Type (2015-2020)
Table 31. Global Opioid Induced Constipation Drugs Revenue Market Share by Type (2021-2026)
Table 32. Global Opioid Induced Constipation Drugs Market Size Share by Application (2015-2020)
Table 33. Global Opioid Induced Constipation Drugs Market Size by Application (2015-2020) (Million US$)
Table 34. Global Opioid Induced Constipation Drugs Market Size Share by Application (2021-2026)
Table 35. North America Key Players Opioid Induced Constipation Drugs Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Opioid Induced Constipation Drugs Market Share (2019-2020)
Table 37. North America Opioid Induced Constipation Drugs Market Size by Type (2015-2020) (Million US$)
Table 38. North America Opioid Induced Constipation Drugs Market Share by Type (2015-2020)
Table 39. North America Opioid Induced Constipation Drugs Market Size by Application (2015-2020) (Million US$)
Table 40. North America Opioid Induced Constipation Drugs Market Share by Application (2015-2020)
Table 41. Europe Key Players Opioid Induced Constipation Drugs Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Opioid Induced Constipation Drugs Market Share (2019-2020)
Table 43. Europe Opioid Induced Constipation Drugs Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Opioid Induced Constipation Drugs Market Share by Type (2015-2020)
Table 45. Europe Opioid Induced Constipation Drugs Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Opioid Induced Constipation Drugs Market Share by Application (2015-2020)
Table 47. China Key Players Opioid Induced Constipation Drugs Revenue (2019-2020) (Million US$)
Table 48. China Key Players Opioid Induced Constipation Drugs Market Share (2019-2020)
Table 49. China Opioid Induced Constipation Drugs Market Size by Type (2015-2020) (Million US$)
Table 50. China Opioid Induced Constipation Drugs Market Share by Type (2015-2020)
Table 51. China Opioid Induced Constipation Drugs Market Size by Application (2015-2020) (Million US$)
Table 52. China Opioid Induced Constipation Drugs Market Share by Application (2015-2020)
Table 53. Japan Key Players Opioid Induced Constipation Drugs Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Opioid Induced Constipation Drugs Market Share (2019-2020)
Table 55. Japan Opioid Induced Constipation Drugs Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Opioid Induced Constipation Drugs Market Share by Type (2015-2020)
Table 57. Japan Opioid Induced Constipation Drugs Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Opioid Induced Constipation Drugs Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Opioid Induced Constipation Drugs Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Opioid Induced Constipation Drugs Market Share (2019-2020)
Table 61. Southeast Asia Opioid Induced Constipation Drugs Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Opioid Induced Constipation Drugs Market Share by Type (2015-2020)
Table 63. Southeast Asia Opioid Induced Constipation Drugs Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Opioid Induced Constipation Drugs Market Share by Application (2015-2020)
Table 65. India Key Players Opioid Induced Constipation Drugs Revenue (2019-2020) (Million US$)
Table 66. India Key Players Opioid Induced Constipation Drugs Market Share (2019-2020)
Table 67. India Opioid Induced Constipation Drugs Market Size by Type (2015-2020) (Million US$)
Table 68. India Opioid Induced Constipation Drugs Market Share by Type (2015-2020)
Table 69. India Opioid Induced Constipation Drugs Market Size by Application (2015-2020) (Million US$)
Table 70. India Opioid Induced Constipation Drugs Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Opioid Induced Constipation Drugs Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Opioid Induced Constipation Drugs Market Share (2019-2020)
Table 73. Central & South America Opioid Induced Constipation Drugs Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Opioid Induced Constipation Drugs Market Share by Type (2015-2020)
Table 75. Central & South America Opioid Induced Constipation Drugs Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Opioid Induced Constipation Drugs Market Share by Application (2015-2020)
Table 77. Ironwood Pharmaceuticals Inc Company Details
Table 78. Ironwood Pharmaceuticals Inc Business Overview
Table 79. Ironwood Pharmaceuticals Inc Product
Table 80. Ironwood Pharmaceuticals Inc Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 81. Ironwood Pharmaceuticals Inc Recent Development
Table 82. Daiichi Sankyo Co Ltd Company Details
Table 83. Daiichi Sankyo Co Ltd Business Overview
Table 84. Daiichi Sankyo Co Ltd Product
Table 85. Daiichi Sankyo Co Ltd Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 86. Daiichi Sankyo Co Ltd Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Product
Table 90. Pfizer Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 91. Pfizer Recent Development
Table 92. Progenics Pharmaceuticals Inc Company Details
Table 93. Progenics Pharmaceuticals Inc Business Overview
Table 94. Progenics Pharmaceuticals Inc Product
Table 95. Progenics Pharmaceuticals Inc Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 96. Progenics Pharmaceuticals Inc Recent Development
Table 97. Shionogi & Co., Ltd Company Details
Table 98. Shionogi & Co., Ltd Business Overview
Table 99. Shionogi & Co., Ltd Product
Table 100. Shionogi & Co., Ltd Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 101. Shionogi & Co., Ltd Recent Development
Table 102. Allergan Plc Company Details
Table 103. Allergan Plc Business Overview
Table 104. Allergan Plc Product
Table 105. Allergan Plc Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 106. Allergan Plc Recent Development
Table 107. Nektar Therapeutics Company Details
Table 108. Nektar Therapeutics Business Overview
Table 109. Nektar Therapeutics Product
Table 110. Nektar Therapeutics Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 111. Nektar Therapeutics Recent Development
Table 112. Purdue Pharma Business Overview
Table 113. Purdue Pharma Product
Table 114. Purdue Pharma Company Details
Table 115. Purdue Pharma Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 116. Purdue Pharma Recent Development
Table 117. S.L.A. Pharma AG Company Details
Table 118. S.L.A. Pharma AG Business Overview
Table 119. S.L.A. Pharma AG Product
Table 120. S.L.A. Pharma AG Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 121. S.L.A. Pharma AG Recent Development
Table 122. Mundipharma International Limited Company Details
Table 123. Mundipharma International Limited Business Overview
Table 124. Mundipharma International Limited Product
Table 125. Mundipharma International Limited Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 126. Mundipharma International Limited Recent Development
Table 127. Ono Pharmaceutical Co., Ltd Company Details
Table 128. Ono Pharmaceutical Co., Ltd Business Overview
Table 129. Ono Pharmaceutical Co., Ltd Product
Table 130. Ono Pharmaceutical Co., Ltd Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 131. Ono Pharmaceutical Co., Ltd Recent Development
Table 132. Takeda Pharmaceutical Company Limited Company Details
Table 133. Takeda Pharmaceutical Company Limited Business Overview
Table 134. Takeda Pharmaceutical Company Limited Product
Table 135. Takeda Pharmaceutical Company Limited Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 136. Takeda Pharmaceutical Company Limited Recent Development
Table 137. Theravance Biopharma Inc Company Details
Table 138. Theravance Biopharma Inc Business Overview
Table 139. Theravance Biopharma Inc Product
Table 140. Theravance Biopharma Inc Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 141. Theravance Biopharma Inc Recent Development
Table 142. Bausch Health Company Details
Table 143. Bausch Health Business Overview
Table 144. Bausch Health Product
Table 145. Bausch Health Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 146. Bausch Health Recent Development
Table 147. Cosmo Pharmaceuticals SA Company Details
Table 148. Cosmo Pharmaceuticals SA Business Overview
Table 149. Cosmo Pharmaceuticals SA Product
Table 150. Cosmo Pharmaceuticals SA Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 151. Cosmo Pharmaceuticals SA Recent Development
Table 152. Daewoong Pharmaceutical Company Details
Table 153. Daewoong Pharmaceutical Business Overview
Table 154. Daewoong Pharmaceutical Product
Table 155. Daewoong Pharmaceutical Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 156. Daewoong Pharmaceutical Recent Development
Table 157. C.B. Fleet Company Company Details
Table 158. C.B. Fleet Company Business Overview
Table 159. C.B. Fleet Company Product
Table 160. C.B. Fleet Company Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 161. C.B. Fleet Company Recent Development
Table 162. Sucampo Pharmaceuticals Company Details
Table 163. Sucampo Pharmaceuticals Business Overview
Table 164. Sucampo Pharmaceuticals Product
Table 165. Sucampo Pharmaceuticals Revenue in Opioid Induced Constipation Drugs Business (2015-2020) (Million US$)
Table 166. Sucampo Pharmaceuticals Recent Development
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioid Induced Constipation Drugs Market Share by Type: 2020 VS 2026
Figure 2. Lubiprostone Features
Figure 3. Methyl Naltrexone Bromide Features
Figure 4. Naldemedine Features
Figure 5. Alvimopan Features
Figure 6. Other Features
Figure 7. Global Opioid Induced Constipation Drugs Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Opioid Induced Constipation Drugs Report Years Considered
Figure 12. Global Opioid Induced Constipation Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Opioid Induced Constipation Drugs Market Share by Regions: 2020 VS 2026
Figure 14. Global Opioid Induced Constipation Drugs Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Opioid Induced Constipation Drugs Market Share by Players in 2019
Figure 17. Global Top Opioid Induced Constipation Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Constipation Drugs as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Opioid Induced Constipation Drugs Revenue in 2019
Figure 19. North America Opioid Induced Constipation Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Opioid Induced Constipation Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Opioid Induced Constipation Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Opioid Induced Constipation Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Opioid Induced Constipation Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Opioid Induced Constipation Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Opioid Induced Constipation Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs